#38 Infant Formula
Guest: Steven Abrams, MD
February 2022
SUBSCRIBE:
Show Notes
Disclosures
A grant from Primary Children’s Hospital is associated with this CME activity. They have no influence over the speakers or content.
Disclosure of Financial Relationships and Resolution of Conflicts of Interest for KAAP CME Activities
The KAAP CME program develops, maintains, and improves the competence, skills, and professional performance of pediatricians and pediatric healthcare professionals by providing quality, relevant, accessible, and effective educational experiences that address gaps in professional practice. The KAAP CME program strives to meet the educational needs of pediatricians and pediatric healthcare professionals and support their lifelong learning with a goal of improving care for children and families.
KAAP recognizes that there are a variety of financial relationships between individuals and commercial interests that require review to identify possible conflicts of interest in a CME activity. KAAP strives to ensure quality, objective, balanced, and scientifically rigorous CME activities by identifying and resolving all potential conflicts of interest prior to the confirmation of service of those in a position to influence and/or control CME content. KAAP has taken steps to resolve any potential conflicts of interest.
All KAAP CME activities will strictly adhere to the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support: Standards to Ensure the Independence of CME Activities. In accordance with these Standards, the following decisions will be made free of the control of a commercial interest: identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the CME activity.
The purpose of this policy is to ensure all potential conflicts of interest are identified and mechanisms to resolve them prior to the CME activity are implemented in ways that are consistent with the public good. KAAP is committed to providing learners with commercially unbiased CME activities.
DISCLOSURE OF FINANCIAL RELATIONSHIPS
All individuals in a position to influence and/or control the content of CME activities are required to disclose to KAAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content.
* A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Disclosure of Commercial Support for AAP CME Activities
A grant from Primary Children’s Hospital is associated with this CME activity. They have no influence over the speakers or content.
| Name | Role |
Relevant Financial Relationship (Please indicate Yes or No) |
Name of Commercial Interest(s)* Please list name(s) of entity AND Nature of Relevant Financial Relationship(s) (Please list: Research Grant, Speaker’s Bureau, Stock/Bonds excluding mutual funds, Consultant, Other – identify) |
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products (Do intend to discuss or Do not intend to discuss) |
| Paul Wirkus | Planner/Moderator | NO | NONE | Do not intend to discuss |
| Steven Abrams | Faculty | YES |
Perrigo Nutrition Abbott Nutrition
|
Do not intend to discuss |
| Carolyn Reynolds | Planner | NO | NONE | Do not intend to discuss |
| Alisa Stoddard | UTAAP Staff/COI Reviewer-Resolver | NO | NONE | Do not intend to discuss |
ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP. Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians.
AMA Credit Designation Statement
Kansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Guest: Steve Abrams, MD
Quiz available after 4th episode airs, typically the fourth week of the month.
Virtual Curbside Podcast – Infant Nutrition
Release date: February 7, 2022
Expiration date: February 6, 2025
Last review date: February 25, 2022
Claim for Credit
- Learners who complete the activity are eligible for 1.0 AMA PRA Category 1 Credit TM.
- Learners who complete all quiz questions, and who meet the 50% minimum passing score requirements, will be eligible for 1.0 MOC Part 2 points.
Learning Objectives
After listening to these episodes listeners will…
- Understand the challenges associated with supporting breastfeeding in the United States
- Recognize the different types of formulas available for use in healthy infants
- Be able to provide advice and counseling to families attempting to select formulas for use in their infant health
Notes
Abbott Nutrition announced a voluntary recall of infant powdered formula manufactured at their Sturgis facility in Michigan, including Similac, Alimentum, and EleCare. This recall comes after four consumer complaints related to Cronobacter sakazakii and Salmonella. Parents and caregivers of infants who have used these products and have concerns about the health of their child should contact the child’s health care provider.
The U.S. Food and Drug Administration (FDA) alerted consumers to avoid purchasing and using infant powdered formula from Abbott Nutrition’s Sturgis, Michigan facility. The FDA is also investigating these consumer complaints of infections and has initiated an onsite inspection of the facility.
The FDA is advising consumers not to use Similac, Alimentum, or Elecare powdered infant formulas if the following is included in the product’s lot number:
- The first two digits of the code are 22 through 37; and
- The code on the container contains K8, SH or Z2; and
- The expiration date is 4-1-2022 (APR 2022) or later.
Abbott has also developed a web-based tool to determine if the consumer’s product was included in this recall. Consumers can click here to check their product’s lot number, located at the bottom of their product.
Please note that this is a targeted recall and does not affect all Abbott products. The recall does not include liquid formula products or any metabolic deficiency nutrition formulas. The FDA states that consumers should continue to use all products not covered by the advisory. As WIC providers have consistently echoed during the COVID-19 pandemic, the FDA advises parents and caregivers to never dilute infant formula and to never make or feed homemade infant formula to infants.
Thus far, consumer complaints included four instances of infant illnesses across three states, including Minnesota, Ohio, and Texas. In all four cases, infants were hospitalized and Cronobacter may have contributed to death in one case. Abbott product manufactured in Michigan was distributed across the country. Cronobacter bacteria can cause life-threatening infections like sepsis or meningitis. Symptoms may include poor feeding, irritability, temperature changes, jaundice, grunting breaths and abnormal movements. Salmonella are a group of bacteria that can cause gastrointestinal illness and symptoms like diarrhea, fever, and abdominal cramps.
1.800.986.8540
Acknowledgements
Written and Hosted by: Paul Wirkus, MD, FAAP
Administrator/Producer/Photographer: Alisa Stoddard, UTAAP Executive Director
Audio Engineer: Alisa Stoddard
Music by: Phil Wirkus
Guest: Steven Abrams, MD
Questions? Send us an email.